AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

QT Imaging Inc. (QTI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.49

0.02 (4.79%)

At close: Jan 21, 2025, 3:59 PM

0.52

5.80%

After-hours Jan 21, 2025, 07:35 PM EST

undefined% (undefined)

Bid	0.49
Market Cap	10.73M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.4
PE Ratio (ttm)	-1.23
Forward PE	n/a
Analyst	n/a

Ask	0.52
Volume	410,899
Avg. Volume (20D)	247,076
Open	0.49
Previous Close	0.47
Day's Range	0.49 - 0.53
52-Week Range	0.35 - 14.40
Beta	undefined

About QTI

QT Imaging Holdings, Inc. engages in the manufacturing, research, and development of automated breast imaging system for producing high-resolution transmission ultrasound images. It offers QT Ultrasound Breast Scanner that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California....

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Mar 5, 2024

Employees 10

Stock Exchange NASDAQ

Ticker Symbol QTI

Website https://www.qtimaging.com

Why Price Moved

9 months ago

+11.43%

QT Imaging Holdings shares are trading higher afte... Unlock content with Pro Subscription

News

1 week ago · businesswire.com

QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) (the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging sys...

2 months ago · businesswire.com

QT Imaging Granted Renewal of NIH Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased ...